{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:16Z","timestamp":1784751856551,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA020024"],"award-info":[{"award-number":["DA020024"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA018197"],"award-info":[{"award-number":["DA018197"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA013045"],"award-info":[{"award-number":["DA013045"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA013035"],"award-info":[{"award-number":["DA013035"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA013046"],"award-info":[{"award-number":["DA013046"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA015815"],"award-info":[{"award-number":["DA015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA026120"],"award-info":[{"award-number":["DA026120"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Toomim Family Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00228-022-03302-5","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T12:02:42Z","timestamp":1645876962000},"page":"965-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2583-0233","authenticated-orcid":false,"given":"David A.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robrina","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Hillhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikla","family":"Shmueli-Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Shores-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverlyn D.","family":"Settles-Reaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rotrosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,26]]},"reference":[{"key":"3302_CR1","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/add.13375","volume":"111","author":"W Ling","year":"2016","unstructured":"Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J (2016) Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the cocaine use reduction with buprenorphine (CURB) study. Addiction 111:1416\u20131427","journal-title":"Addiction"},{"key":"3302_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cct.2012.11.002","volume":"34","author":"LJ Mooney","year":"2013","unstructured":"Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W (2013) Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. Contemp Clin Trials 34:196\u2013204","journal-title":"Contemp Clin Trials"},{"key":"3302_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1570159043359477","volume":"2","author":"K Lutfy","year":"2004","unstructured":"Lutfy K, Cowan A (2004) Buprenorphine: a unique drug with complex pharmacology. Curr Neuropharmacol 2:395\u2013402","journal-title":"Curr Neuropharmacol"},{"key":"3302_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137\u2013151","journal-title":"Nat Rev Neurosci"},{"key":"3302_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0376-8716(98)00071-4","volume":"51","author":"H Akil","year":"1998","unstructured":"Akil H, Owens C, Gutstein H, Taylor L, Curran E, Watson S (1998) Endogenous opioids: overview and current issues. Drug Alcohol Depend 51:127\u2013140","journal-title":"Drug Alcohol Depend"},{"key":"3302_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0306-4522(96)00002-4","volume":"72","author":"YL Hurd","year":"1996","unstructured":"Hurd YL (1996) Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 72:767\u2013783","journal-title":"Neuroscience"},{"key":"3302_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/cne.903500307","volume":"350","author":"A Mansour","year":"1994","unstructured":"Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350:412\u2013438","journal-title":"J Comp Neurol"},{"key":"3302_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/syn.890180106","volume":"18","author":"JB Daunais","year":"1994","unstructured":"Daunais JB, McGinty JF (1994) Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18:35\u201345","journal-title":"Synapse"},{"key":"3302_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00001756-199305000-00020","volume":"4","author":"JB Daunais","year":"1993","unstructured":"Daunais JB, Roberts DC, McGinty JF (1993) Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. NeuroReport 4:543\u2013546","journal-title":"NeuroReport"},{"key":"3302_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0169-328X(92)90058-J","volume":"13","author":"YL Hurd","year":"1992","unstructured":"Hurd YL, Brown EE, Finlay JM, Fibiger HC, Gerfen CR (1992) Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res Mol Brain Res 13:165\u2013170","journal-title":"Brain Res Mol Brain Res"},{"key":"3302_CR11","first-page":"818","volume":"250","author":"SP Sivam","year":"1989","unstructured":"Sivam SP (1989) Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 250:818\u2013824","journal-title":"J Pharmacol Exp Ther"},{"key":"3302_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0169-328X(93)90133-A","volume":"19","author":"R Spangler","year":"1993","unstructured":"Spangler R, Unterwald EM, Kreek MJ (1993) \u2018Binge\u2019 cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res 19:323\u2013327","journal-title":"Brain Res Mol Brain Res"},{"key":"3302_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0361-9230(01)00496-8","volume":"55","author":"V Yuferov","year":"2001","unstructured":"Yuferov V, Zhou Y, LaForge KS, Spangler R, Ho A, Kreek MJ (2001) Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by \u201cbinge\u201d pattern cocaine administration. Brain Res Bull 55:65\u201370","journal-title":"Brain Res Bull"},{"key":"3302_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","volume":"681","author":"SD Glick","year":"1995","unstructured":"Glick SD, Maisonneuve IM, Raucci J, Archer S (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147\u2013152","journal-title":"Brain Res"},{"key":"3302_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s002130051016","volume":"144","author":"S Schenk","year":"1999","unstructured":"Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology 144:339\u2013346","journal-title":"Psychopharmacology"},{"key":"3302_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/syn.10251","volume":"50","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Schlussman SD, Ho A, Kreek MJ (2003) Effect of chronic \u201cbinge cocaine\u201d on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of c57bl\/6j and 129\/j mice. Synapse 50:191\u2013199","journal-title":"Synapse"},{"key":"3302_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-2999(98)00637-2","volume":"358","author":"AV Kuzmin","year":"1998","unstructured":"Kuzmin AV, Gerrits MA, Van Ree JM (1998) Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats. Eur J Pharmacol 358:197\u2013202","journal-title":"Eur J Pharmacol"},{"key":"3302_CR18","first-page":"44","volume":"282","author":"SS Negus","year":"1997","unstructured":"Negus SS, Mello NK, Portoghese PS, Lin CE (1997) Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 282:44\u201355","journal-title":"J Pharmacol Exp Ther"},{"key":"3302_CR19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/npp.2008.187","volume":"34","author":"V Yuferov","year":"2009","unstructured":"Yuferov V, Ji F, Nielsen DA, Levran O, Ho A, Morgello S, Shi R, Ott J, Kreek MJ (2009) A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34:1185\u20131197","journal-title":"Neuropsychopharmacology"},{"key":"3302_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1601-183X.2012.00785.x","volume":"11","author":"TK Clarke","year":"2012","unstructured":"Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O\u2019Brien CP, Oslin DW, Lohoff FW (2012) Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes Brain Behav 11:415\u2013423","journal-title":"Genes Brain Behav"},{"key":"3302_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2011.02.010","volume":"85","author":"SG Wei","year":"2011","unstructured":"Wei SG, Zhu YS, Lai JH, Xue HX, Chai ZQ, Li SB (2011) Association between heroin dependence and prodynorphin gene polymorphisms. Brain Res Bull 85:238\u2013242","journal-title":"Brain Res Bull"},{"key":"3302_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1369-1600.2009.00151.x","volume":"14","author":"TK Clarke","year":"2009","unstructured":"Clarke TK, Krause K, Li T, Schumann G (2009) An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Addict Biol 14:366\u2013370","journal-title":"Addict Biol"},{"key":"3302_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1369-1600.2010.00248.x","volume":"16","author":"M Rouault","year":"2011","unstructured":"Rouault M, Nielsen DA, Ho A, Kreek MJ, Yuferov V (2011) Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity. Addict Biol 16:334\u2013346","journal-title":"Addict Biol"},{"key":"3302_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D (2002) The human genome browser at UCSC. Genome Res 12:996\u20131006","journal-title":"Genome Res"},{"key":"3302_CR25","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1755-0998.2009.02591.x","volume":"9","author":"MJ Hubisz","year":"2009","unstructured":"Hubisz MJ, Falush D, Stephens M, Pritchard JK (2009) Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour 9:1322\u20131332","journal-title":"Mol Ecol Resour"},{"key":"3302_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1086\/302959","volume":"67","author":"JK Pritchard","year":"2000","unstructured":"Pritchard JK, Stephens M, Rosenberg NA, Donnelly P (2000) Association mapping in structured populations. Am J Hum Genet 67:170\u2013181","journal-title":"Am J Hum Genet"},{"key":"3302_CR27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1086\/501531","volume":"78","author":"O Lao","year":"2006","unstructured":"Lao O, van Duijn K, Kersbergen P, de Knijff P, Kayser M (2006) Proportioning whole-genome single-nucleotide-polymorphism diversity for the identification of geographic population structure and genetic ancestry. Am J Hum Genet 78:680\u2013690","journal-title":"Am J Hum Genet"},{"key":"3302_CR28","unstructured":"R Development Core Team (2009) R: a language and environment for statistical computing. In: R Foundation for Statistical Computing, Vienna, Austria"},{"key":"3302_CR29","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum, Hillsdale, NJ"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03302-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03302-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03302-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T08:05:46Z","timestamp":1652515546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03302-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3302"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03302-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,26]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The parent study and genetic sub-study were approved by the Institutional Review Boards of the participating sites as well as by the Institutional Review Board of the Baylor College of Medicine and the Research and Development Committee of the Michael E. DeBakey Veterans Affairs Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Drs. Nielsen, Graham, Hamon, Hillhouse, Shmueli-Blumberg, Lawson, Shores-Wilson, Settles-Reaves, Rotrosen, Ling and Kosten, and Nielsen declare no potential conflict of interest. Drs. Rotrosen, Walker, and Trivedi have served as PI or co-I on studies for which Reckitt Benckiser Pharmaceuticals\/Indivior and\/or Alkermes have contributed funds, medication, or both. Dr. Trivedi has received compensation as a member of the scientific advisory board of Alkermes Pharmaceuticals and owns stock in the company. Dr. Saxon received compensation as an advisory board member to Alkermes Pharmaceuticals and also received travel support from Alkermes as well as royalties from UpToDate, Inc. and research support from Medicasafe, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}